Related Experiment Video

Updated: May 14, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in

Daisuke Takagi1, Yasutoshi Tatsumi, Tomoki Yokochi

  • 1Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan.

Cancer Science
|January 31, 2013
PubMed

Insights

Src homology 2 domain containing F (Shf) interacts with anaplastic lymphoma kinase (ALK) in neuroblastoma. High Shf and low ALK expression correlate with better neuroblastoma prognosis, suggesting Shf inhibits ALK signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a pediatric cancer with variable prognosis.
  • Anaplastic lymphoma kinase (ALK) is an oncogenic driver in neuroblastoma.
  • Src homology 2 domain containing F (Shf) is an adaptor protein implicated in cancer.

Purpose of the Study:

  • To investigate the interaction between Shf and ALK in neuroblastoma.
  • To determine the functional role of Shf in ALK signaling and neuroblastoma progression.
  • To assess the prognostic significance of Shf and ALK expression levels.

Main Methods:

  • Real-time PCR for mRNA expression analysis.
  • Co-immunoprecipitation to study protein interactions.
  • siRNA-mediated knockdown and overexpression studies to assess functional impact.
  • Analysis of downstream signaling pathways (Erk1/2, STAT3).

Main Results:

  • Shf interacts with ALK in neuroblastoma cells.
  • High Shf mRNA expression is associated with non-metastatic neuroblastoma.
  • Low ALK and high Shf expression correlate with better patient prognosis.
  • Shf knockdown enhances ALK phosphorylation, downstream signaling (Erk1/2, STAT3), cellular growth, mobility, and invasion.
  • Overexpression of ALK mimics Shf knockdown effects.

Conclusions:

  • Shf negatively regulates the ALK-initiated signal transduction pathway in neuroblastoma.
  • Shf acts as a tumor suppressor by inhibiting ALK-mediated oncogenesis.
  • Shf expression levels can serve as a prognostic biomarker for neuroblastoma.

More Related Videos

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line08:07

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Published on: February 17, 2016

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...